SCHEMBL5360422

SCHEMBL5360422

N#Cc1cc(Cc2ccccc2Cl)ccc1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.43
SLC6A2 P23975 2/20 0.42
SLC6A4 P31645 2/20 0.42
SLC6A3 Q01959 2/20 0.42
ALDH1A1 P00352 2/20 0.39
LMNA P02545 2/20 0.39
KDM4E B2RXH2 1/20 0.39
SNCA P37840 1/20 0.39
PNMT P11086 1/20 0.38
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
MPO P05164 1/20 0.35
IDO1 P14902 3/20 0.35
DAO P14920 1/20 0.34
ANPEP P15144 1/20 0.34
PRKACA P17612 1/20 0.34
PRKACG P22612 1/20 0.34
PRKACB P22694 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11057646 0.80 CYP3A4 (0.48) CYP3A4ALDH1A1LMNAKDM4ESNCA
SCHEMBL5351161 0.80 CYP3A4 (0.56) CYP3A4SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL5360516 0.79 IDH1 (0.43) CYP3A4ALDH1A1LMNAKDM4EPRKACA
SCHEMBL5350773 0.78 ALDH1A1 (0.47) ALDH1A1KDM4ESNCAADORA2AADORA1
SCHEMBL5360561 0.78 CYP3A4 (0.48) CYP3A4ALDH1A1KDM4ESNCAGAA
SCHEMBL5370698 0.77 CYP3A4 (0.44) CYP3A4ALDH1A1KDM4EPNMTTAAR1
SCHEMBL5414685 0.75 CA1 (0.45) CYP3A4ALDH1A1KDM4ETAAR1MPO
SCHEMBL15445886 0.74 SLC5A2 (0.46) SLC6A2SLC6A4SLC6A3ALDH1A1LMNA
SCHEMBL23195304 0.74 KHK (0.39) CYP3A4SLC6A2SLC6A4PNMTADORA2A
SCHEMBL8385915 0.72 MAOB (0.48) ALDH1A1LMNAKDM4ETAAR1PRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7256197-B2 Methods for synthesis of diarylmethanes DANA-FARBER CANCER INSTITUTE (US) 2007-08-14 US disclosed
US-20040267011-A1 Methods for synthesis of diarylmethanes DANA-FARBER CANCER INSTITUTE 2004-12-30 US disclosed
WO-2003031458-A1 METHODS FOR SYNTHESIS OF DIARYLMETHANES DANA-FARBER CANCER INSTITUTE (US) 2003-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040267011-A1 Methods for synthesis of diarylmethanes DHFR, DPYD, DHODH CYP3A4 92/4885SLC6A2 2281/4885SLC6A4 1710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.